| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NexImmune, Inc. | Chief Financial Officer | Common Stock | 186,969 | $76,713 | $0.4103 | 22 Nov 2022 | Direct |
| NexImmune, Inc. | Chief Financial Officer | Stock Option (right to buy) | 13,727 | 04 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123023686-trainer-john-2023-04-04 | NexImmune, Inc. | 04 Apr 2023 | 10 | $0 | 4 | Chief Financial Officer | 06 Apr 2023, 20:41 |
| /report/000120919122058801-trainer-john-2022-11-22 | NexImmune, Inc. | 22 Nov 2022 | 1 | $0 | 4 | Chief Financial Officer | 25 Nov 2022, 16:05 |
| /report/000120919122023745-trainer-john-2022-04-05 | NexImmune, Inc. | 05 Apr 2022 | 1 | $0 | 4 | Chief Financial Officer | 07 Apr 2022, 19:11 |
| /report/000120919121046170-trainer-john-2021-07-08 | NexImmune, Inc. | 08 Jul 2021 | 2 | +$17,743 | 4 | Chief Financial Officer | 09 Jul 2021, 16:19 |
| /report/000120919121039163-trainer-john-2021-06-08 | NexImmune, Inc. | 08 Jun 2021 | 2 | +$17,743 | 4 | Chief Financial Officer | 09 Jun 2021, 16:06 |
| /report/000120919121033999-trainer-john-2021-04-08 | NexImmune, Inc. | 08 Apr 2021 | 4 | +$35,487 | 4 | Chief Financial Officer | 19 May 2021, 16:16 |